US hospital initiative improves on-time administration of Parkinson’s medication

News

Author: Simge Eva DoganPublished: 16 July 2020

Prep: Cook: Serves:

Late or missed doses of Parkinson’s medication in hospitals can lead to longer stays and greater morbidity. To counteract this issue, a team of healthcare professionals in the US launched a project to improve the on-time administration of medication to people with the condition.

As part of the initiative – published in the Journal of Parkinson’s Disease – several measures were implemented, including electronic alerts for nurses, stocking automated medication dispensing machines, reporting to nurse unit managers on timeliness of medication administration and more.

Dr Martha A Nance, the project’s lead investigator, said: “This project was very rewarding for our team, because of its obvious, immediate, and important impact on patient care.

“We have reason to think that timely administration of carbidopa-levodopa may be associated with shorter stays and better outcomes and satisfaction. Anecdotally, patients have reported being surprised and pleased that nurses were reminding them that medication doses were due soon, rather than the other way around!”

To read more on this topic click here.

For more information on Parkinson’s and hospital admission please visit the EPDA website.

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Last Month

Next Month

Go Back

Share this story

Comments

Europe

Creative and living with Parkinson’s? Showcase your work in the Mervyn Peake Awards

Art competition: get your entries in for a chance to exhibit work

Women and Parkinson’s: “Being pregnant was scary”

One woman’s poignant account of pregnancy and Parkinson’s

Campaigners slam Ryanair for Parkinson’s ‘drunk’ flight ban

No-fly zone for holidaymaker with Parkinson’s

Is there a link between Parkinson’s disease and blood vessel dysfunction?

Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.

New swab test may help with Parkinson’s disease diagnosis

Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

US hospital initiative improves on-time administration of Parkinson’s medication

News

Author: Simge Eva DoganPublished: 16 July 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Europe

Creative and living with Parkinson’s? Showcase your work in the Mervyn Peake Awards

Women and Parkinson's

Women and Parkinson’s: “Being pregnant was scary”

Perspectives

Campaigners slam Ryanair for Parkinson’s ‘drunk’ flight ban

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

US hospital initiative improves on-time administration of Parkinson’s medication

News

Author: Simge Eva DoganPublished: 16 July 2020

Last Month

Next Month

Share this story

Comments

Related articles

Europe

Creative and living with Parkinson’s? Showcase your work in the Mervyn Peake Awards

Women and Parkinson's

Women and Parkinson’s: “Being pregnant was scary”

Perspectives

Campaigners slam Ryanair for Parkinson’s ‘drunk’ flight ban

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

Sign in